Moore Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-65,000
Closed -$22.8M 700
2025
Q4
$22.8M Buy
65,000
+35,026
+117% +$11.8M 0.33% 74
2025
Q3
$9.69M Buy
29,974
+17,953
+149% +$5.58M 0.13% 155
2025
Q2
$4.68M Sell
12,021
-14,521
-55% -$5.84M 0.06% 230
2025
Q1
$11.5M Buy
26,542
+25,528
+2,518% +$10.2M 0.24% 87
2024
Q4
$374K Sell
1,014
-38,986
-97% -$16.3M ﹤0.01% 426
2024
Q3
$20.8M Buy
40,000
+20,000
+100% +$10.7M 0.38% 69
2024
Q2
$10.8M Buy
+20,000
New +$10.6M 0.19% 128
2023
Q2
Sell
-1,000
Closed -$460K 539
2023
Q1
$460K Buy
+1,000
New +$476K 0.01% 326
2022
Q2
Sell
-24,434
Closed -$12M 721
2022
Q1
$12M Buy
+24,434
New +$11.2M 0.31% 63
2021
Q1
Sell
-33,909
Closed -$10.9M 703
2020
Q4
$10.9M Buy
+33,909
New +$10.4M 0.12% 125
2015
Q4
Sell
-35,000
Closed -$4.9M 312
2015
Q3
$4.9M Sell
35,000
-108,216
-76% -$16.3M 0.23% 144
2015
Q2
$23.5M Buy
143,216
+129,919
+977% +$20.8M 0.51% 36
2015
Q1
$2.05M Buy
+13,297
New +$1.89M 0.05% 271
2014
Q4
Sell
-124,400
Closed -$14.9M 335
2014
Q3
$14.9M Buy
+124,400
New +$14.3M 0.35% 72
2014
Q2
Sell
-4,674
Closed -$465K 498
2014
Q1
$465K Buy
+4,674
New +$423K 0.01% 360
2013
Q3
Sell
-15,000
Closed -$1.23M 374
2013
Q2
$1.23M Buy
+15,000
New +$1.12M 0.03% 239

Other funds holding ELV

Moore Capital Management's ELV Position: Q1 2026 in Review

Moore Capital Management sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 65,000 shares — an estimated $22.8M sold.

Moore Capital Management first reported a position in ELV in Q2 2013 and held it in 16 quarters. The position peaked at $23.5M in Q2 2015. 1,469 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Moore Capital Management reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Moore Capital Management sold 65,000 Elevance Health shares in Q1 2026, an estimated $22.8M.
  • Moore Capital Management first reported a position in Elevance Health in Q2 2013 and held it in 16 quarters.
  • Moore Capital Management's Elevance Health position peaked at $23.5M in Q2 2015.
  • 1,469 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Moore Capital Management's 13F filing for Q1 2026, filed 15 May 2026.